Trials / Completed
CompletedNCT00987506
Evaluation of a XIENCE V® Endoprothesis Used for Coronary Angioplasty, for LPPR (List of Reimbursable Products and Services) Indications in Patients Monitored for 2 Years in France
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,165 (actual)
- Sponsor
- Abbott Medical Devices · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to prepare elements of response to the Haute Autorité de Santé (High Health Authority) of France, which is expecting data relating to the routine use of XIENCE V® endoprothesis within the 5 years following its marketing.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | XIENCE V® | Participants with placement of a XIENCE V® EESS |
Timeline
- Start date
- 2008-06-01
- Primary completion
- 2010-12-01
- Completion
- 2011-12-01
- First posted
- 2009-10-01
- Last updated
- 2012-04-19
Locations
58 sites across 1 country: France
Source: ClinicalTrials.gov record NCT00987506. Inclusion in this directory is not an endorsement.